As noted above, MDM2 itself is a transcriptional target of p53, and thus, in addition to suppressing tumor growth, p53 activation is expected to cause a temporary increase in MDM2 expression levels in tumor cells [34]. This evidence concerns the gene TP53 and neoplasm.